The Body's Own Cannabis System May Play a Role in ADHD
A review of 13 studies found emerging evidence that endocannabinoid system dysregulation may contribute to ADHD, with preclinical studies showing links between altered cannabinoid signaling and hyperactivity and impaired cognitive control.
Quick Facts
What This Study Found
Eleven preclinical and 2 clinical studies showed alterations in endocannabinoid system components linked to ADHD-related behaviors. Preclinical research demonstrated ECS changes connected to hyperactivity and impaired cognitive regulation. Clinical evidence, while limited, showed promising results supporting ECS-targeted therapeutic approaches.
Key Numbers
13 studies included (11 preclinical, 2 clinical); ECS components examined: cannabinoid receptors, endogenous ligands, metabolic enzymes; pathways affected: dopaminergic, noradrenergic, glutamatergic.
How They Did This
Narrative review synthesizing 13 studies (11 preclinical, 2 clinical) evaluating ECS-related biochemical alterations in ADHD, focusing on receptor signaling, ligand levels, and enzyme activity.
Why This Research Matters
ADHD affects millions worldwide, and current treatments (stimulants) are not effective for everyone and carry side effects. If the endocannabinoid system plays a role in ADHD, it could open entirely new treatment avenues, though much more research is needed.
The Bigger Picture
The endocannabinoid system modulates the same neurotransmitter systems (dopamine, noradrenaline, glutamate) that are central to ADHD pathophysiology. This review highlights a potential but underexplored connection that could inform future therapeutic development.
What This Study Doesn't Tell Us
Only 13 studies met inclusion criteria, reflecting how little research exists in this area. Only 2 were clinical studies. Preclinical models of ADHD may not fully capture the human condition. Review methodology is narrative rather than systematic.
Questions This Raises
- ?Would cannabinoid-based treatments help ADHD symptoms?
- ?How do current ADHD medications interact with the endocannabinoid system?
- ?Could ECS biomarkers help diagnose or stratify ADHD subtypes?
Trust & Context
- Key Stat:
- Only 13 studies (mostly preclinical) have examined the endocannabinoid system's role in ADHD
- Evidence Grade:
- Preliminary: Narrative review of a very small evidence base (13 studies, mostly preclinical) exploring an early-stage research question.
- Study Age:
- Published in 2025.
- Original Title:
- Biochemical Role of the Endocannabinoid System in the Pathophysiology of Attention Deficit Hyperactivity Disorder: A Narrative Review and Future Directions.
- Published In:
- Neurochemical research, 51(1), 16 (2025)
- Database ID:
- RTHC-07291
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Should people with ADHD use cannabis?
This review does not support or recommend cannabis use for ADHD. It identifies a potential biological connection between the endocannabinoid system and ADHD that needs much more research. Cannabis use may worsen attention in the short term, regardless of underlying ADHD.
How might the endocannabinoid system relate to ADHD?
The endocannabinoid system modulates dopamine, noradrenaline, and glutamate pathways, all of which are central to attention and behavioral control. If ECS function is disrupted, it could contribute to the neurotransmitter imbalances seen in ADHD.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
- cannabis-effects-and-experience-science
- why-more-creative-when-high-thc-divergent
- thc-and-discipline-daily-use-willpower
- thc-creative-work-artists-musicians-writers
Cite This Study
https://rethinkthc.com/research/RTHC-07291APA
Özmeral Erarkadaş, Kübra; Erarkadaş, Müjdat; Yıldız Gündoğdu, Özlem. (2025). Biochemical Role of the Endocannabinoid System in the Pathophysiology of Attention Deficit Hyperactivity Disorder: A Narrative Review and Future Directions.. Neurochemical research, 51(1), 16. https://doi.org/10.1007/s11064-025-04636-z
MLA
Özmeral Erarkadaş, Kübra, et al. "Biochemical Role of the Endocannabinoid System in the Pathophysiology of Attention Deficit Hyperactivity Disorder: A Narrative Review and Future Directions.." Neurochemical research, 2025. https://doi.org/10.1007/s11064-025-04636-z
RethinkTHC
RethinkTHC Research Database. "Biochemical Role of the Endocannabinoid System in the Pathop..." RTHC-07291. Retrieved from https://rethinkthc.com/research/ozmeral-2025-biochemical-role-of-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.